Blog Archives

How Much Will Serum Institute’s Covishield Vaccine Cost? Adar Poonawalla Answers Source:India Adar Poonawalla also claimed that SII’s Covishield will be cheaper than the vaccine developed by Pfizer-BioNTech New Delhi: A day after India’s drugs regulator approved Oxford COVID-19 vaccine Covishield, Serum Institute of India (SII) CEO Adar Poonawalla revealed the prices of the vaccine, saying that it will commercially be available at Rs 1,000 per dose if the Centre allows its sale in the private market. Also Read – India’s COVID-19 Tally Rises Marginally With Over 18,000 Cases in 24 Hours Yesterday, Drugs Controller General of India (DCGI) had approved Covishield and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country on the basis of recommendations by a COVID-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). ...

COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine – Check price here Source:Zeenews The vaccination drive for the vaccine against COVID-19 is expected to begin in India in the coming days. The Drug Controller General of India (DCGI) Dr VG Somani on Sunday (January 3) approved Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for emergency use against coronavirus. The much-awaited approval by DGCI paved the way for the roll-out of these vaccines in India. Meanwhile, the Serum Institute of India CEO Adar Poonawalla on Sunday revealed the prices of Covishield and disclosed that his company has fixed two different prices for the vaccine. Poonawalla announced that Covishield will be given at Rs 250 to the government and the vaccine will be available in the private market for Rs 1,000. According to Poonawalla, Serum’s Covishield is cheaper than the vaccine developed by Pfizer-BioNTech and its transportation is also ...